Citation

NH Tobin, GM Aldrovandi. Are infants unique in their ability to be "functionally cured" of HIV-1. Current HIV/AIDS Reports. 2014 Mar 20; 11(1):1-10. PMID: 24390641.

Citation

KB Larson, K Wang, C Delille, I Otofokun, EP Acosta. Pharmacokinetic Enhancers in HIV Therapeutics. Clinical Pharmacokinetics. 2014 Oct 20; 53(10):865-872. PMID: 25164142.

Citation

Sharon Nachman, Nan Zheng, Edward P Acosta, Hedy Teppler, Brenda Homony, Bobbie Graham, Terence Fenton, Xia Xu, Larissa Wenning, Stephen A Spector, Lisa M Frenkel, Carmelita Alvero, Carol Worrell, Edward Handelsman, Andrew Winzia, International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) P1066 Study Team. Pharmacokinetics, Safety, and 48-Week Efficacy of Oral Raltegravir in HIV-1–Infected Children Aged 2 Through 18 Years. Clinical Infectious Diseases. 2014 Feb 15; 58(3):413-422. PMID: 24145879; PMCID: PMC3890333.

Citation

Jane C Lindsey, Michael D Hughes, Avy Violari, Susan H Eshleman, Elaine J Abrams, Mutsa Bwakura-Dangarembizi, Linda Barlow-Mosha, Portia Kamthunzi, Pauline M Sambo, Mark F Cotton, Harry Moultrie, Sandhya Khadse, Werner Schimana, Raziya Bobat, Bonnie Zimmer, Elizabeth Petzold, Lynne M Mofenson, Patrick Jean-Philippe, Paul Palumbo, International Maternal Pediatric Adolescent AIDS Clinical Trials Group (IMPAACT) P1060 Study Team. Predictors of virologic and clinical response to nevirapine versus lopinavir/ritonavir-based antiretroviral therapy in young children with and without prior nevirapine exposure for the prevention of mother-to-child HIV transmission. Pediaric Infectious Disease Journal. 2014 Aug 15; 33(8):846-854. PMID: 25222305; PMCID: PMC4166566.

Citation

Dwight E Yin, Meredith G Warshaw, William C Miller, Hannah Castro, Susan A Fiscus, Lynda M Harper, Linda J Harrison, Nigel J Klein, Joanna Lewis, Ann J Melvin, Gareth Tudor-Williams, Ross E McKinney Jr, PENPACT-1 (PENTA 9/PACTG 390) Study Team. Using CD4 percentage and age to optimize pediatric antiretroviral therapy initiation. 2014 Oct 01; PMID: 25266426; PMCID: PMC4179097.

Citation

Discordant associations between SLCO1B1 521T¿C and plasma levels of ritonavir-boosted protease inhibitors in AIDS clinical trials group study A5146. Therapeutic Drug Monitoring. 2013 Apr 01; 35(2):209-216. PMID: 23503447; PMCID: PMC3603284.

Citation

Participation and retention of youth with perinatal HIV infection in mental health research studies: the IMPAACT P1055 Psychiatric Comorbidity Study. Journal of Acquired Immune Deficiency Syndromes. 2013 Jul 01; 63(3):401-9. PMID: 23714737; PMCID: PMC3683105.

Citation

Raltegravir In Vitro Effect on Bilirubin Binding. Pediaric Infectious Disease Journal. 2013 Sep 01; 32(9):978-980. PMID: 23470680; PMCID: PMC3856729.

Citation

CA Beneri, B Zeldow, S Nachman, M Van der Linde, E Pillay, S Dittmer, S Kim, P Jean-Philippe, J Coetzee, R Bobat, E Hawkins, A Violari, P1041 Team. Loss to follow-up among infants in a study of isoniazid prophylaxis (P1041) in South Africa. International Journal of Tuberculosis and Lung Disease. 2013 Jan 01; 17(1):32-38. PMID: 23232002; PMCID: PMC3556820.

Citation

Social Ecological Predictors of Longitudinal Pediatric HIV Treatment Adherence. Journal of Pediatric Psychology. 2013 Jul 01; 38(6):664-74. PMID: 23629146; PMCID: PMC3701127.